Pharmasset, Inc.

Pharmasset had three clinical-stage product candidates for the treatment of chronic hepatitis C virus advancing in trials.

1 documented relationship

Hover or select an entity to isolate its relationships. Link thickness reflects the documented amount.

Detailed register

Mr. Robert WilliamsonBoard seatPharmasset, Inc.
Reported^{2Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapiestriumvira.com}
Role or object indicated by the source: “early Director”.

Sources

1.
Gilead Sciences to Acquire Pharmasset Inc for 11 Billion
Web pagegilead.com
View original ↑ Back to text
2.
Board of Directors Archives - Triumvira Immunologics | Engineered T Cell Therapies
Web pagetriumvira.com
View original ↑ Back to text